AA
JNJ icon

AlphaCentric Advisors’s Johnson & Johnson JNJ Stock Holding History

AlphaCentric Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Buy
1,391
+81
+6% +$18.9K 0.3% 115
2026
Q1 		$320K Buy
+1,310
New +$305K 0.32% 98
2024
Q4 		$2.63M Buy
+18,176
New +$2.82M 2.62% 3
2023
Q4 		– Sell
-1,426
Closed -$222K – 265
2023
Q3 		$222K Sell
1,426
-45
-3% -$7.42K 0.13% 134
2023
Q2 		$243K Sell
1,471
-106
-7% -$17.1K 0.14% 127
2023
Q1 		$244K Sell
1,577
-19
-1% -$3.07K 0.17% 130
2022
Q4 		$282K Buy
+1,596
New +$276K 0.28% 103

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AlphaCentric Advisors's JNJ Position: Q2 2026 in Review

AlphaCentric Advisors increased its Johnson & Johnson (JNJ) stake by 6.2% in Q2 2026, buying an estimated $18.9K and bringing the position to 1,391 shares worth $353K. The position accounts for 0.3% of the portfolio, ranked #115.

AlphaCentric Advisors first reported a position in JNJ in Q4 2022 and has held it in 7 quarters since. The position peaked at $2.63M in Q4 2024. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • AlphaCentric Advisors held 1,391 shares of Johnson & Johnson worth $353K as of Q2 2026.
  • AlphaCentric Advisors bought 81 Johnson & Johnson shares in Q2 2026, an estimated $18.9K.
  • Johnson & Johnson made up 0.3% of AlphaCentric Advisors's portfolio in Q2 2026, its #115 holding.
  • AlphaCentric Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 7 quarters since.
  • AlphaCentric Advisors's Johnson & Johnson position peaked at $2.63M in Q4 2024.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.